Enzymatica AB (OSTO:ENZY) E10: kr-0.35 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ENZY Enzymatica AB OSTO:ENZY
58 GF Score
Price kr1.85
GF Value kr2.13
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Enzymatica AB E10?

Enzymatica AB OSTO:ENZY -0.27% 58 E10 is kr-0.35 as of Jun. 2026. GuruFocus rates OSTO:ENZY with a GF Score™ of 58/100 and a GF Value™ of kr2.13 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Enzymatica AB's adjusted earnings per share data for the three months ended in Jun. 2026 was kr-0.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-0.35 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average E10 Growth Rate was 17.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Enzymatica AB was 17.40% per year. The lowest was 4.90% per year. And the median was 11.15% per year.

As of today (2026-07-29), Enzymatica AB's current stock price is kr1.845. Enzymatica AB's E10 for the quarter that ended in Jun. 2026 was kr-0.35. Enzymatica AB's Shiller PE Ratio of today is .


Enzymatica AB  (OSTO:ENZY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Enzymatica AB E10 Related Terms


Enzymatica AB E10 Historical Data

* Premium members only.

The historical data trend for Enzymatica AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzymatica AB E10 Chart

Enzymatica AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.64 -0.71 -0.67 -0.55 -0.40

Enzymatica AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.48 -0.43 -0.40 -0.37 -0.35

OSTO:ENZY vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Enzymatica AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzymatica AB Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzymatica AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Enzymatica AB's Shiller PE Ratio falls into.


OSTO:ENZY
58GF Score
Enzymatica AB OSTO:ENZY
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enzymatica AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Enzymatica AB's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.05/134.1100*134.1100
=-0.050

Current CPI (Jun. 2026) = 134.1100.

Enzymatica AB Quarterly Data

per share eps CPI Adj_EPS
201609 -0.072 101.138 -0.095
201612 -0.180 102.022 -0.237
201703 -0.117 102.022 -0.154
201706 -0.108 102.752 -0.141
201709 -0.036 103.279 -0.047
201712 -0.072 103.793 -0.093
201803 -0.102 103.962 -0.132
201806 -0.157 104.875 -0.201
201809 -0.102 105.679 -0.129
201812 -0.055 105.912 -0.070
201903 -0.083 105.886 -0.105
201906 -0.102 106.742 -0.128
201909 -0.046 107.214 -0.058
201912 -0.037 107.766 -0.046
202003 0.009 106.563 0.011
202006 -0.074 107.498 -0.092
202009 -0.009 107.635 -0.011
202012 0.000 108.296 0.000
202103 -0.055 108.360 -0.068
202106 -0.129 108.928 -0.159
202109 -0.037 110.338 -0.045
202112 -0.065 112.486 -0.077
202203 -0.111 114.825 -0.130
202206 -0.092 118.384 -0.104
202209 -0.074 122.296 -0.081
202212 -0.120 126.365 -0.127
202303 -0.083 127.042 -0.088
202306 -0.065 129.407 -0.067
202309 -0.055 130.224 -0.057
202312 -0.083 131.912 -0.084
202403 -0.102 132.205 -0.103
202406 -0.074 132.716 -0.075
202409 -0.040 132.304 -0.041
202412 -0.050 132.987 -0.050
202503 -0.070 132.825 -0.071
202506 -0.060 133.699 -0.060
202509 -0.030 133.480 -0.030
202512 -0.050 133.390 -0.050
202603 -0.060 133.560 -0.060
202606 -0.050 134.110 -0.050

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-0.35 mean?
Enzymatica AB (OSTO:ENZY) has a E10 of kr-0.35 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Enzymatica AB and its competitors.
Is Enzymatica AB's E10 too high?
Enzymatica AB's current E10 is kr-0.35. Overall, Enzymatica AB has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Enzymatica AB's E10 compare to ZTS?
Enzymatica AB's E10 of kr-0.35 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Enzymatica AB and its competitors. Enzymatica AB's current E10 is kr-0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzymatica AB stock overvalued right now?
Based on GuruFocus' analysis, Enzymatica AB (OSTO:ENZY) is currently considered Modestly Undervalued. The stock's GF Value™ is kr2.13, compared to a current price of kr1.85 — trading 13.4% below its estimated fair value. The current E10 is kr-0.35. Enzymatica AB's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Enzymatica AB (OSTO:ENZY), the current E10 is kr-0.35 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enzymatica AB (OSTO:ENZY) Overvalued in 2026?

Based on GuruFocus' analysis, Enzymatica AB stock appears to be undervalued. The current stock price of kr1.85 is trading 13.4% below its estimated GF Value™ of kr2.13. GuruFocus considers Enzymatica AB to be Modestly Undervalued.

Key valuation signals for OSTO:ENZY:

  • E10: kr-0.35
  • GF Value™: kr2.13 vs. price of kr1.85 (13.4% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the OSTO:ENZY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Enzymatica AB Business Description

Other Exchanges EN9:Germany
Address Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.
58GF Score

Get the complete analysis for OSTO:ENZY

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.85
Price
kr2.13
GF Value